Cargando…

Baseline Conservative and Surgical Management in the Treatment of NSAID-Exacerbated Respiratory Disease

Non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (N-ERD) is a chronic medical condition that includes asthma, chronic rhinosinusitis with nasal polyposis, and hypersensitivity to aspirin and other NSAIDs. Eosinophilic inflammation in the upper and lower airways is treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sillanpää, Saara, Numminen, Jura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Allergy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974786/ https://www.ncbi.nlm.nih.gov/pubmed/35387049 http://dx.doi.org/10.3389/falgy.2021.659887

Ejemplares similares

Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
por: Van Broeck, Dorien, et al.
Publicado: (2023)

Factors affecting upper airway control of NSAID‐exacerbated respiratory disease: A real‐world study of 167 patients
por: Lyly, Annina, et al.
Publicado: (2021)

Patient-Reported Control of Asthma, Nasal Polyposis, and Middle-Ear Symptoms in NSAID-Exacerbated Respiratory Disease
por: Suikkila, Anna, et al.
Publicado: (2021)

Aspirin desensitization in nonsteroidal anti-inflammatory exacerbated respiratory disease: The first prospective cohort in Chile
por: Siña, María Josefina, et al.
Publicado: (2023)

Hypersensitivity to intravenous succinate corticosteroids in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease
por: Taniguchi, Masami, et al.
Publicado: (2023)

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
por: Sehanobish, Esha, et al.
Publicado: (2021)

Potential Biomarkers for NSAID-Exacerbated Respiratory Disease
por: Park, Hanki, et al.
Publicado: (2017)

The Rhinobiome of Exacerbated Wheezers and Asthmatics: Insights From a German Pediatric Exacerbation Network
por: Aydin, Malik, et al.
Publicado: (2021)

NSAID-exacerbated respiratory disease: a population study
por: Andersén, Heidi, et al.
Publicado: (2022)

Aspirin‐exacerbated respiratory disease: A review
por: Dominas, Christine, et al.
Publicado: (2020)

Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
por: Laidlaw, Tanya M.
Publicado: (2018)

Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease
por: Schneider, Sven, et al.
Publicado: (2023)

Recurrent Wheeze Exacerbations Following Acute Bronchiolitis—A Machine Learning Approach
por: Makrinioti, Heidi, et al.
Publicado: (2021)

Immunoglobulin E-Dependent Activation of Immune Cells in Rhinovirus-Induced Asthma Exacerbation
por: Kawakami, Toshiaki, et al.
Publicado: (2022)

NSAID-Exacerbated Respiratory Disease (NERD): From Pathogenesis to Improved Care
por: Woo, Seong-Dae, et al.
Publicado: (2020)

Complementary Participation of Genetics and Epigenetics in Development of NSAID-exacerbated Respiratory Disease
por: Lee, Jong-Uk, et al.
Publicado: (2019)

Hypersensitivity reactions to biologics used in the treatment of allergic diseases: clinical features, diagnosis and management
por: Sitek, Andrea, et al.
Publicado: (2023)

Airway Basal Cells, Protectors of Epithelial Walls in Health and Respiratory Diseases
por: Ruysseveldt, Emma, et al.
Publicado: (2021)

Nutritional management of food allergies: Prevention and treatment
por: Leone, Ludovica, et al.
Publicado: (2023)

The role of the respiratory microbiome in asthma
por: Campbell, Christina D., et al.
Publicado: (2023)

Risk factors of NSAID‐exacerbated respiratory disease: A population‐based study
por: Helevä, Alma, et al.
Publicado: (2023)

Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease
por: Rhyou, Hyo-In, et al.
Publicado: (2022)

Respiratory Viral and Bacterial Factors That Influence Early Childhood Asthma
por: Mthembu, Nontobeko, et al.
Publicado: (2021)

The MaDo real-life study of dose adjustment of allergen immunotherapy liquid formulations in an indication of respiratory allergic disease: Reasons, practices, and outcomes
por: Thétis-Soulié, Marguerite, et al.
Publicado: (2022)

Impact of Therapeutics on Unified Immunity During Allergic Asthma and Respiratory Infections
por: Flores-Torres, Armando S., et al.
Publicado: (2022)

EUFOREA summit in Brussels 2023: inspiring the future of allergy & respiratory care
por: Hellings, P. W., et al.
Publicado: (2023)

Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions
por: Backer, Vibeke, et al.
Publicado: (2023)

Nitric Oxide in the Management of Respiratory Consequences in COVID-19: A Scoping Review of a Different Treatment Approach
por: Ghosh, Arunibha, et al.
Publicado: (2022)

Mammalian derived lipocalin and secretoglobin respiratory allergens strongly bind ligands with potentially immune modulating properties
por: Janssen-Weets, Bente, et al.
Publicado: (2022)

Characterization of the upper respiratory tract microbiota in Chilean asthmatic children reveals compositional, functional, and structural differences
por: Ramos-Tapia, Ignacio, et al.
Publicado: (2023)

Maternal and paternal tuberculosis is associated with increased asthma and respiratory symptoms in their offspring: a study from Northern Europe
por: Gyawali, Sanjay, et al.
Publicado: (2023)

Immune Metabolism–An Opportunity to Better Understand Allergic Pathology and Improve Treatment of Allergic Diseases?
por: Goretzki, Alexandra, et al.
Publicado: (2022)

Editorial: Diagnosis and management of allergy to chemotherapy and biologics
por: Madrigal-Burgaleta, Ricardo, et al.
Publicado: (2023)

Environmental allergen reduction in asthma management: an overview
por: Pham, Duy Le, et al.
Publicado: (2023)

Editorial: Antibiotic allergy de-labelling and management
por: Roizen, Gigia, et al.
Publicado: (2023)

Pregnancy-Induced Exacerbation of Hereditary Angioedema in a Multiparous Caucasian Female
por: Sankrithi, Praveen, et al.
Publicado: (2020)

Improvement of eosinophilic chronic rhinosinusitis after infection with severe acute respiratory syndrome corona virus 2 during dupilumab therapy: A case report
por: Koike-Ieki, Mariko, et al.
Publicado: (2023)

Investigation of the Relationship between Aspirin-Sensitivity and Poor Response to Medical Management in NSAIDs-exacerbated Respiratory Disease Patients with Sinonasal Polyposis
por: Nabavi, Mohammad, et al.
Publicado: (2023)

Acute Urticaria and Anaphylaxis: Differences and Similarities in Clinical Management
por: Ensina, Luis Felipe, et al.
Publicado: (2022)

Editorial: Assessment and management of adverse drug reactions in oncology
por: Tsai, Ping-Feng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bbr3ri9q5nl0lrimchr0fr4trk